Search

Author/Creator Pinter, Andreas

21. Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study. (27th January 2023)

Authors:
Iversen, Lars; Conrad, Curdin; Eidsmo, Liv; Costanzo, Antonio; Narbutt, Joanna; Pinter, Andreas; Kingo, Külli; Rivera Diaz, Raquel; Kolbinger, Frank; Nanna, ManikPrabhu; Frueh, Jennifer Annika; Jagiello, Piotr
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 5(2023)
Page Start:
1004
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial. (1st June 2022)

Authors:
Augustin, Matthias; Reich, Kristian; Yamauchi, Paul; Pinter, Andreas; Bagel, Jerry; Dahale, Swapnil; You, Ruquan; Bruin, Gerard; Djimopoulos, Jimena; Paguet, Bertrand; Charef, Pascal; Patekar, Manmath; Keefe, Deborah
Journal:
British journal of dermatology
Issue:
Volume 186:Number 6(2022)
Page Start:
942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial. (8th April 2022)

Authors:
Augustin, Matthias; Reich, Kristian; Yamauchi, Paul; Pinter, Andreas; Bagel, Jerry; Dahale, Swapnil; You, Ruquan; Bruin, Gerard; Djimopoulos, Jimena; Paguet, Bertrand; Charef, Pascal; Patekar, Manmath; Keefe, Deborah
Journal:
British journal of dermatology
Issue:
Volume 186:Number 6(2022)
Page Start:
942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. Issue 1 (December 2016)

Authors:
Hrgovic, Igor; Doll, Monika; Kleemann, Johannes; Wang, Xiao-Fan; Zoeller, Nadja; Pinter, Andreas; Kippenberger, Stefan; Kaufmann, Roland; Meissner, Markus
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30th EADV Congress 2021. (22nd December 2022)

Authors:
Pinter, Andreas; van de Kerkhof, Peter
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 2(2023)supplement 1
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Topische Therapie bei Psoriasis vulgaris – ein Behandlungspfad. (18th March 2019)

Authors:
Körber, Andreas; Wilsmann‐Theis, Dagmar; Augustin, Matthias; von Kiedrowski, Ralph; Mrowietz, Ulrich; Rosenbach, Thomas; Meller, Stephan; Pinter, Andreas; Sticherling, Michael; Gerdes, Sascha
Journal:
Journal der Deutschen Dermatologischen Gesellschaft
Issue:
Volume 17(2019)Supplement 4
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗